
PrEP - pre-exposure prophylaxis


(MedicalXpress) ICAP’s Wafaa El-Sadr on HPTN 083 Injectable PrEP Results
The HIV Prevention Trials Network (HPTN) announced results from HPTN 083, a global randomized, controlled, double-blind study that compared the safety and efficacy of long-acting injectable cabotegravir (CAB LA) to daily oral tenofovir/emtricitabine (TDF/FTC)...
Two Wins for ICAP in CUGH-Pulitzer Global Health Video Competition
Two ICAP videos won honors in the 7th Annual CUGH-Pulitzer Global Health Video Competition, held by the Colleges and Universities in Global Health (CUGH). First place in the High Impact Programs Category went to the Population-based HIV Impact Assessment (PHIA)...
New ICAP Video Explores the Power of PrEP in Nigeria
As part of a combination prevention package, PrEP (or pre-exposure prophylaxis) is proving to be a key intervention to stemming the tide of new HIV infections, particularly those most at-risk for contracting the virus including people who inject drugs, men who have...